1 / 12

Methodological Issues in Systematic Reviews: Assessing Omega-3 Fatty Acids and Cardiovascular Disease

This presentation by Joseph Lau, MD, focuses on methodological issues in systematic reviews, specifically addressing the efficacy and safety of omega-3 fatty acids (DHA, EPA, ALA) in preventing cardiovascular disease (CVD). Key questions explored include the effects of omega-3 sources on CVD outcomes in both primary and secondary prevention populations, and adverse events associated with omega-3 supplements. The presentation highlights the importance of careful question formulation using the PICO method to guide research on interventions, considering the balance between broad and narrow inquiries.

simone
Télécharger la présentation

Methodological Issues in Systematic Reviews: Assessing Omega-3 Fatty Acids and Cardiovascular Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Methodological Issues in Systematic Review- Formulating Questions - Joseph Lau, MD Tufts Medical Center EPC AHRQ Annual Meeting September 10, 2008

  2. Analytic framework for omega-3 FA intake and CVD

  3. Specific Key Questions • What is the efficacy or association of omega-3 fatty acids (DHA, EPA or ALA supplements, and fish consumption) in reducing CVD events (including all-cause mortality, CVD mortality, non-fatal CVD events, and new diagnosis of CVD)? In patients without known CVD (primary prevention) and with known CVD (secondary prevention).

  4. Specific Key Questions 2. Relative effects of omega-3 fatty acid sources, with specific emphasis on compositions, dosages, the ratio of omega-6 to omega-3 fatty acids, and potential interactions due to duration of intervention or exposure. • What adverse events related to omega-3 fatty acid dietary supplements are reported in studies?

  5. Participants • Primary Prevention - patients without prior history of cardiovascular disease • Country • Background diet • Secondary Prevention – patients with prior history of cardiovascular disease

  6. Interventions • Fish • Different kinds, preparation, amount, how intake was estimated • Fish oil supplements • Eicosapentaenoic acid (EPA) / Docosahexaenoic acid (DHA) • α-linolenic acid [ALA] (walnut, canola oil, flax seed, etc.)

  7. Outcomes (endpoints) • Clinical outcomes (events) • Overall mortality • Stroke • Myocardial infarction • Sudden death • revascularization • Surrogate/intermediate outcomes (biomarkers, measurements) • Blood pressure • Lipid levels

  8. The PICO method to formulate research question on interventions

  9. Study design • RCT • Cohort • Case-control • Cross-sectional • Other criteria • Study size • Year, language, etc

  10. Additional inclusion criteria • Published English language literature • Experimental or observational studies • Reported original CVD outcome data and evaluated any potential source of omega-3 fatty acids • At least 5 human subjects • At least 1-year duration

  11. Issues in formulating a question • Narrow versus broad (for individual or population) • Clinically meaningful and useful (based on sound biological and epidemiological principles) • Very broadly defined questions may be criticized for mixing apples and oranges • Very narrowly focused questions may have no data or have limited generalizability and sometimes may lead to misinterpretations

More Related